MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 210 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $608,000 | +82.6% | 19,978 | +55.9% | 0.16% | +82.2% |
| Q1 2022 | $333,000 | +47.3% | 12,813 | +15.4% | 0.09% | +16.9% |
| Q4 2021 | $226,000 | +8.1% | 11,100 | +2.2% | 0.08% | +13.2% |
| Q3 2021 | $209,000 | +0.5% | 10,860 | -11.3% | 0.07% | -56.1% |
| Q3 2020 | $208,000 | +3.5% | 12,243 | -40.4% | 0.16% | +150.0% |
| Q4 2019 | $201,000 | +19.6% | 20,535 | +82.3% | 0.06% | -45.6% |
| Q3 2018 | $168,000 | -24.3% | 11,266 | -27.9% | 0.11% | -39.0% |
| Q1 2018 | $222,000 | – | 15,620 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |